Remove Journal Remove Startup Remove Study Remove Technical Review
article thumbnail

The Perfect Pithy And Productive Investor Pitch

InfoChachkie

When seeking the perfect pitch, in baseball and in the startup world, less is a lot more. In a recent Wall Street Journal article , Brad Keywell noted that, while the average New York city elevator ride is 118seconds, most adults non-task focused attention span is closer to 8seconds. Google x Facebook x Amazon) + (Universal Reviews).

Product 208
article thumbnail

Interview with Alan Horsager, Episona

socalTECH

Our interview today is with Alan Horsager , the CEO of Pasadena-based Episona (www.episona.com), an angel backed startup which has already developed and has been offering up an epigenetic test for male fertility. We've translated that into a screening test, which started offering out in October of last year.

USC 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

US Economic Risks (Sept 2010): Impact on Investors & Entrepreneurs

Both Sides of the Table

This post was originally published in a shorter (more sensible) format in the Wall Street Journal online. The prices of angel deals have recently crept up, VCs have also gotten their checkbooks out again, frothy deals are happening and people are feeling bullish. raise money now to weather any storms).

article thumbnail

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. Everyone is waiting until 2017, when huge studies of the drugs’ ability to prevent heart attacks and strokes start to provide data. Be our guest and try it.). Time for the gold-medal roundup.

article thumbnail

Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More

Xconomy

Just last month, a startup Tsien cofounded announced a round of funding to push ahead with a fluorescent technology that aims to help surgeons cut out tumors without removing healthy tissue. —Healthcare giant Novartis (NYSE: NOV ) is breaking up its cell and gene therapy R&D group , laying off roughly 30 percent of staff. .

News 57
article thumbnail

Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More

Xconomy

government’s Precision Medicine Initiative is an ambitious effort to collect the genomic data of 1 million Americans, and tech giant Alphabet (NASDAQ: GOOG ) is deeply involved. That story and the rest of the week’s biotech headlines below. —The U.S. —David H. In the U.S.,

Google 40
article thumbnail

Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More

Xconomy

” One of her most recent projects was a biotech startup in concert with industry veteran Tony Coles (pictured with Lindquist, above). The Mayo Clinic cardiologist behind the report published a study earlier this year about long QT misdiagnosis leading to improper defibrillator implants. DRUG PROBLEMS. ” ASH THURSDAY.